Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe paediatric pulmonary hypertension: new management strategies.

Literature DB >> 15613526

Severe paediatric pulmonary hypertension: new management strategies.

Abstract

Pulmonary hypertension is a significant complication in many paediatric disease states. This article discusses current understanding of pulmonary hypertension and includes definition, diagnosis, and management. A description of the latest advances in targeted pharmacological therapy in children is also provided as well as impact on morbidity and mortality.

Entities: Disease Species

Mesh：

Substances：

Year: 2005 PMID： 15613526 PMCID： PMC1720073 DOI： 10.1136/adc.2003.048744

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

50 in total

1. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.

Authors: M Berner; M Beghetti; I Spahr-Schopfer; I Oberhansli; B Friedli
Journal: Am J Cardiol Date: 1996-03-01 Impact factor: 2.778

2. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.

Authors: J Pepke-Zaba; T W Higenbottam; A T Dinh-Xuan; D Stone; J Wallwork
Journal: Lancet Date: 1991-11-09 Impact factor: 79.321

3. Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension.

Authors: A Davidson; A Bossuyt; I Dab
Journal: Pediatr Pulmonol Date: 1989

4. Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension.

Authors: D Dunbar Ivy; Donna Parker; Aimee Doran; Donna Parker; John P Kinsella; Steven H Abman
Journal: Am J Cardiol Date: 2003-10-01 Impact factor: 2.778

5. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury.

Authors: Peter Dahlem; Wim M C van Aalderen; Marjorie de Neef; Marcel G W Dijkgraaf; Albert P Bos
Journal: Crit Care Med Date: 2004-04 Impact factor: 7.598

6. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

Authors: D L Wessel; I Adatia; T M Giglia; J E Thompson; T J Kulik
Journal: Circulation Date: 1993-11 Impact factor: 29.690

7. Sitaxsentan therapy for pulmonary arterial hypertension.

Authors: Robyn J Barst; David Langleben; Adaani Frost; Evelyn M Horn; Ronald Oudiz; Shelley Shapiro; Vallerie McLaughlin; Nicholas Hill; Victor F Tapson; Ivan M Robbins; Diane Zwicke; Benjamin Duncan; Richard A F Dixon; Lyn R Frumkin
Journal: Am J Respir Crit Care Med Date: 2003-11-20 Impact factor: 21.405

8. Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease.

Authors: D D Ivy; J P Kinsella; R R Wolfe; S H Abman
Journal: Am J Cardiol Date: 1996-01-01 Impact factor: 2.778

9. Primary pulmonary hypertension in children: clinical characterization and survival.

Authors: J Sandoval; O Bauerle; A Gomez; A Palomar; M L Martínez Guerra; M E Furuya
Journal: J Am Coll Cardiol Date: 1995-02 Impact factor: 24.094

10. Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.

Authors: R L Geggel; A J Dozor; D C Fyler; L M Reid
Journal: Am Rev Respir Dis Date: 1985-04

15 in total

1. Portopulmonary hypertension in pediatric patients.

Authors: Adria A Condino; D Dunbar Ivy; Judith A O'Connor; Michael R Narkewicz; Sarah Mengshol; John R Whitworth; Lori Claussen; Aimee Doran; Ronald J Sokol
Journal: J Pediatr Date: 2005-07 Impact factor: 4.406

2. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal: Chest Date: 2012-02 Impact factor: 9.410

3. Refractory pulmonary hypertension following extremely preterm birth: paradoxical improvement in oxygenation after atrial septostomy.

Authors: Hiroki Saitsu; Osuke Iwata; Junichiro Okada; Akiko Hirose; Hiroshi Kanda; Toyojiro Matsuishi; Kenji Suda; Yasuki Maeno
Journal: Eur J Pediatr Date: 2013-08-03 Impact factor: 3.183

4. Simulations of congenital septal defect closure and reactivity testing in patient-specific models of the pediatric pulmonary vasculature: A 3D numerical study with fluid-structure interaction.

Authors: Kendall S Hunter; Craig J Lanning; Shiuh-Yung J Chen; Yanhang Zhang; Ruchira Garg; D Dunbar Ivy; Robin Shandas
Journal: J Biomech Eng Date: 2006-08 Impact factor: 2.097

Review 5. Pulmonary arterial hypertension: a comparison between children and adults.

Authors: R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal: Eur Respir J Date: 2011-03 Impact factor: 16.671

6. Application of a microstructural constitutive model of the pulmonary artery to patient-specific studies: validation and effect of orthotropy.

Authors: Yanhang Zhang; Martin L Dunn; Kendall S Hunter; Craig Lanning; D Dunbar Ivy; Lori Claussen; S James Chen; Robin Shandas
Journal: J Biomech Eng Date: 2007-04 Impact factor: 2.097